177 related articles for article (PubMed ID: 8864317)
1. Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.
Haagsma CJ; Russel FG; Vree TB; Van Riel PL; Van de Putte LB
Br J Clin Pharmacol; 1996 Aug; 42(2):195-200. PubMed ID: 8864317
[TBL] [Abstract][Full Text] [Related]
2. Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.
Haagsma CJ; van Riel PL; de Rooij DJ; Vree TB; Russel FJ; van't Hof MA; van de Putte LB
Br J Rheumatol; 1994 Nov; 33(11):1049-55. PubMed ID: 7981992
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components.
Dougados M; Combe B; Cantagrel A; Goupille P; Olive P; Schattenkirchner M; Meusser S; Paimela L; Rau R; Zeidler H; Leirisalo-Repo M; Peldan K
Ann Rheum Dis; 1999 Apr; 58(4):220-5. PubMed ID: 10364900
[TBL] [Abstract][Full Text] [Related]
4. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
[TBL] [Abstract][Full Text] [Related]
6. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB
Br J Rheumatol; 1997 Oct; 36(10):1082-8. PubMed ID: 9374925
[TBL] [Abstract][Full Text] [Related]
7. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
Haagsma CJ; van Riel PL; van de Putte LB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():104-8. PubMed ID: 8535640
[TBL] [Abstract][Full Text] [Related]
8. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis.
Nisar M; Carlisle L; Amos RS
Br J Rheumatol; 1994 Jul; 33(7):651-4. PubMed ID: 7912633
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
Carmichael SJ; Beal J; Day RO; Tett SE
J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
[TBL] [Abstract][Full Text] [Related]
12. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
[TBL] [Abstract][Full Text] [Related]
14. Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate.
Koyama Y; Shiraishi H; Ohta T; Uchino A
Mod Rheumatol; 2012 Feb; 22(1):100-8. PubMed ID: 21706263
[TBL] [Abstract][Full Text] [Related]
15. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis.
Nagashima M; Matsuoka T; Saitoh K; Koyama T; Kikuchi O; Yoshino S
Clin Exp Rheumatol; 2006; 24(3):260-7. PubMed ID: 16870092
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of methotrexate for the escape by salazosulfapyridine].
Kawasaki Y; Moriyama M; Shibata K; Gomita Y
Yakugaku Zasshi; 2005 Jul; 125(7):579-82. PubMed ID: 15997214
[TBL] [Abstract][Full Text] [Related]
19. Monitoring methotrexate therapy in patients with rheumatoid arthritis.
Wiela-Hojenska A; Orzechowska-Juzwenko K; Swierkot J; Wiland P; Hurkacz M; Szechinski J
Int J Clin Pharmacol Ther; 2004 Aug; 42(8):434-41. PubMed ID: 15366323
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.
Baraldo M; Ferraccioli G; Pea F; Gremese E; Furlanut M
Pharmacol Res; 1999 Dec; 40(6):483-6. PubMed ID: 10660945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
